Article PDF
References
Al-Arif LI, Goldstein RA, Affronti L, Jameson HW (1978) HLA-Bw15 and tuberculosis in a North American black population. Am Rev Respir Dis 120: 1275
Allen PM (1987) Antigen processing at the molecular level. Immunol Today 8: 270
Benacerraf B (1981) Role of MHC gene products in immune regulation. Science 212: 1229
Benacerraf B, McDevitt HO (1972) Histocompatibility-linked immune response genes. A new class of genes that controls the formation of specific immune responses has been identified. Science 175: 273
Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 506
Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512
Bloom BK, Mehra V (1984) Immunological unresponsiveness in leprosy. Immunol Rev 80: 5
Chakravarrti MR, Vogel F (1973) A twin study on leprosy. In: Beeker PE, Lenz W, Vogel F, Wendt GC (eds) Topics in human genetics, vol 1. Thieme, Stuttgart, pp 1–123
Danielssen DC, Boeck W (1848) In: Traité de la Spédalskhed. Baillière, Paris, pp 81–86
Day NE, Simons MJ (1976) Diseases susceptibility genes—their identification by multiple case family studies. Tissue Antigens 8: 109
De Vries RRP (1979) The HLA system and infectious diseases. Thesis, University of Leiden
De Vries RRP, Van Rood JJ (1985) Introduction. Allergy 36: 1–9
De Vries RRP, Lai A Fat RFM, Nijenhuis LE, Van Rood JJ (1976) HLA-linked genetic control of host response toMycobacterium leprae. Lancet II: 1328
De Vries RRP, Meera Khan P, Bernini LF, Van Loghem E, Van Rood JJ (1979) Genetic control of survival in epidemics. J Immunogenet 6: 271
De Vries RRP, Van Eden W, Van Rood JJ (1981) HLA-linked control of the course ofM. leprae infections. Lepr Rev 52: 109
De Vries RRP, Serjeantson SW, Layrisse Z (1984) Leprosy. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility testing. Springer, Berlin Heidelberg New York Tokyo, pp 362–367
De Vries RRP, Ottenhoff THM, Li Shuguang, Young RA (1986) HLA class II-restricted helper and suppressor clones reactive withMycobacterium leprae. Lepr Rev 57: 113
Fine PEM (1981) Immunogenetics of susceptibility to leprosy, tuberculosis, and Leishmaniasis. Int J Lepr. Other Mycobact Dis 49: 437
Fine PEM, Wolf E, Pritchard J, Watson B, Bradley DJ, Festenstein H, Chacko CJC (1979) HLA-linked genes and leprosy: a family study in Karigiri, South India. J Infect Dis 140: 152
Germain RN (1986) The ins and outs of antigen processing and presentation. Nature 322: 687
Godal T, Negassi K (1973) Subclinical infection in leprosy. Br Med J 3: 557
Godal T, Myrvang B, Stanford J-L, Samuel DR (1974) Recent advances in the immunology of leprosy with special reference to new approaches in immunoprophylaxis. Bull Inst Pasteur 72: 273
Green JR, Woodrow JC (1983) Sibling method for detecting HLA-linked genes in disease. Tissue Antigens 9: 31
Hafez M, ElSalab SH, El-Shennawy F, Bassiory MR (1985) HLA antigens and tuberculosis in the Egyption population. Tubercle 66: 35
Hansen GA (1911) Heredity of leprosy. Arch Demiatol Syphilol 110: 225
Irgens LM (1980) Leprosy in Norway. Lepr Rev 51: 1
Jiang ZF, An JB, Sun YP, Mittal KK, Lee TD (1983) Association of HLA-Bw35 with tuberculosis in the Chinese. Tissue Antigens 22: 86
Lalouel JM, Morton NE (1981) Complex segregation analysis with pointers. Hum Hered 31: 312
Lamb JR, Ivanyi J, Rees ADM, Rothbard JB, Howland K, Young RA, Young DB (1987) Mapping of T cell epitopes using recombinant antigens and synthetic peptides. EMBO J 6: 1245
Landsteiner K (1931) Individual differences in human blood. Science 73: 403
Lilly F, Boyse EA, Old LJ (1964) Genetic base of susceptibility to viral leukaemogenesis. Lancet II: 1207
McDevitt HO, Bodmer WF (1972) Histocompatibility antigens, immune responsiveness and susceptibility to disease. Am J Med 52: 1
McDevitt HO, Chinnitz A (1969) Genetic control of the antibody response: relationship between immune response and histocompatibility (H-2) type. Science 163: 1207
Morton NE, Lalouel JM (1981) Resolution of linkage for irregular phenotype systems. Hum Hered 31: 3
Ottenhoff THM, De Vries RRP (1987) HLA class II immune reponse and suppression genes in leprosy. Int J Lepr Other Mycobacot Dis 55: 521
Ottenhoff THM, Elferink BG, Klatser PR, De Vries RRP (1986) Cloned suppressor T cells from a lepromatous leprosy patient suppressMycobacterium leprae-reactive helper T cells. Nature 322: 462
Ottenhoff THM, Klatser PR, Ivanyi J, Elferink BG, De Wit MYL, De Vries RRP (1986)Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells. Nature 319: 66
Ottenhoff THM, Neuteboom S, Elferink BG, De Vries RRP (1986) Molecular localisation and polymorphism of HLA class II restriction determinants defined byMycobacterium leprae-reactive helper T cell clones from leprosy patients. J Exp Med 164: 1923
Parham P (1988) Presentation and processing of antigens in Paris. Immunol Today 9: 65
Piazza A,. Belvedere MC, Bernoco D, Conighi C, Contu L, Curtoni ES, Mattiuz PL, Mayr W, Richiardi P, Sendeller G, Ceppellini R (1972) HLA-variation in four Sardinian villages under differential selective pressure by malaria. In: Dausset J, Colombani J (eds) Histocompatibility testing. Munksgaard, Copenhagen, pp 73–84
Schwartz RH (1985) Associations in T cell activation. Nature 317: 284
Schwartz RH (1987) Antigen presentation, fugue in T-lymphocyte recognition. Nature 326: 738
Selby R, Barnard JM, Buehler SK, Crumley J, Larsen B, Marshall WH (1978) Tuberculosis associated with HLA-B8, BfS in a Newfoundland community study. Tissue Antigens 11: 403
Serjeantson SW (1982) HLA and susceptibility to leprosy. Immunol Rev 70: 24
Singh SPN, Mehra NK, Dingley HB, Pande JN, Vaidya MC (1983) Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J Infect Dis 148: 676
Shields ED, Russell DA, Perlonk-Vanco MA (1987) Genetic epidemiology of the susceptibility to leprosy. J Clin Invest 79: 1
Spickett SG (1964) Genetic mechanisms in leprosy. In: Cochrane RG, Davey TF (eds) Leprosy in theory and practice. Weight, Bristol, pp 98–124
Svejgaard A, Jersild C, Staub Nielsen L, Bodmer WF (1974) HLA antigens and disease. Statistical and genetical considerations. Tissue Antigens 4: 95
Thole JER, van Schooten WCA, Keulen WJ, Hermans PWM, Janson AAM, de Vries RRP, Kolk AHJ, van Embden JDA (1988) Use of recombinant antigens expressed inEscherichia coli K-12 to map B cell and T cell epitopes on the immunodominant 65-Kilodalton protein ofMycobacterium bovis BCG. Infect Immun 56: 1633
Thomson G (1982) Theoretical aspects of HLA disease associations. In: Bonne-Tamiear B (ed) Human genetics, Part B: Medical aspects. Liss, New York, pp 77–88
Unanue ER, Beller DI, Lu CY, Allen PM (1984) Antigen presentation: comments on its regulation and mechanism. J Immunol 132: 1
Van Eden W, De Vries RRP (1984) HLA and leprosy: a re-evaluation. Lepr Rev 55: 89
Van Eden W, Thole JER, Van der Zee R, Noordzy A, Van Embden JDA, Hensen EJ, Cohen IR (1988) Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331: 171
Weitkamp LR (1981) HLA and disease: predictions for HLA haplotype sharing in families. Am J Hum Genet 33: 776
Wilkinson D, de Vries RRP, Madrigal JA, Lock CB, Morgenstern JP, Trowsdale J, Altmann DM (1988) Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2β gene products and antigen presentation to T cell clones from leprosy patients. J Exp Med 167: 1442
Young DB, Ivanyi J, Cox JH, Lamb JR (1987) The 65-kDa antigen of mycobacteria a common bacterial antigen. Immunol Today 8: 215
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Vries, R.R.P., Ottenboff, T.H.M. & van Schooten, W.C.A. Human leukocyte antigens (HLA) and mycobacterial disease. Springer Semin Immunopathol 10, 305–318 (1988). https://doi.org/10.1007/BF02053843
Issue Date:
DOI: https://doi.org/10.1007/BF02053843